Hypertension,Essential Clinical Trials

12 recruiting

Hypertension,Essential Trials at a Glance

12 actively recruiting trials for hypertension,essential are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Seoul, Baltimore, and Beijing. Lead sponsors running hypertension,essential studies include Addpharma Inc., Boryung Pharmaceutical Co., Ltd, and Ablative Solutions, Inc..

Browse hypertension,essential trials by phase

Treatments under study

About Hypertension,Essential Clinical Trials

Looking for clinical trials for Hypertension,Essential? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hypertension,Essential trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hypertension,Essential clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

Diabetic RetinopathyHypertension,EssentialRetinal Vein Occlusion+1 more
Johns Hopkins University1,050 enrolled1 locationNCT04505618
Recruiting
Not Applicable

Mobile Health Program for Rural Hypertension

Quality of LifeAdherence, MedicationHypertension,Essential
University of Pittsburgh334 enrolled1 locationNCT05546931
Recruiting

The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature

Chronic PainFibromyalgiaArthritis+2 more
Faith A. Richardson25 enrolled1 locationNCT05067998
Recruiting
Phase 3

Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)

HypertensionHypertension,Essential
Ablative Solutions, Inc.142 enrolled1 locationNCT07083765
Recruiting

An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

Hypertension,Essential
Boryung Pharmaceutical Co., Ltd20,000 enrolled1 locationNCT05413057
Recruiting

Types of Intracellular Bacteria in Atherosclerotic Plaques and Analysis of Risk Factors

DiabetesCarotid Artery StenosisHyperlipidemia+6 more
Tang-Du Hospital200 enrolled1 locationNCT06935279
Recruiting
Not Applicable

Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System

Hypertension,EssentialHypertension, Uncontrolled
Istituto Auxologico Italiano480 enrolled8 locationsNCT03206814
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of AD-224

Hypertension,Essential
Addpharma Inc.252 enrolled1 locationNCT06291207
Recruiting
Phase 4

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial

Hypertension,Essential
Xiyuan Hospital of China Academy of Chinese Medical Sciences100 enrolled5 locationsNCT06093932
Recruiting
Phase 3

Phase III Study to Evaluate the Efficacy and Safety of AD-209

Hypertension,Essential
Addpharma Inc.280 enrolled1 locationNCT06348576
Recruiting

Genetic of Response to Acute Saline Load Test in Hypertension (Naload)

Genetic Predisposition to DiseaseHypertension,EssentialSalt; Excess+1 more
Ospedale San Raffaele150 enrolled1 locationNCT04625569
Recruiting
Not Applicable

Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis

Heart FailureAortic Valve StenosisHypertension,Essential
Henrik Wiggers200 enrolled6 locationsNCT04613193